Curio Digital Therapy for the Treatment of Post-partum Depression
Launched by HEALTHCARE INNOVATION TECHNOLOGY LAB · Jul 14, 2023
Trial Information
Current as of May 28, 2025
Active, not recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effectiveness of the MamaLift Plus app as a treatment for postpartum depression (PPD) in women who have recently given birth. The trial compares the use of this app to a control group that receives usual care without the app. The researchers hope to find that women using the MamaLift Plus app will have less severe symptoms of depression over a period of nine weeks compared to those who do not use the app.
To be eligible for this trial, participants must be women aged 18 to 50 who have had a live childbirth within the last three months and have mild to moderate symptoms of postpartum depression, as indicated by a specific screening tool. They should also be able to read and speak English, consent to participate, and have access to a smartphone and the internet. Participants can expect to use the MamaLift Plus app regularly and will receive support throughout the study. It’s important to know that this trial is currently active but not recruiting new participants.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Participants must be able to read, write and speak English; 3. Participants must provide written informed consent prior to enrollment; 4. Participants must be 18 to 50 years of age at the time of enrollment; 5. Participants must have had a live childbirth \<=3 months prior to their enrollment into the study; 6. Participants who have a score of greater than or equal to 13 but not exceeding 19 on the Edinburgh Postnatal Depression Scale (EPDS) during initial screening visit/call; 7. Depression diagnosis needs to be confirmed by licensed behavioral health therapist or medical professional; 8. Participants must answer "0/Never" or "1/Hardly Ever" to the self-harm question on EPDS (Question #10); 9. Participants must be willing to use a mobile app and own an iOS or android enabled mobile phone or device; 10. Participants must have wireless internet connectivity in their home (or have access to internet connectivity) and be willing to connect devices via a Wi-Fi network
- Exclusion Criteria:
- • -
About Healthcare Innovation Technology Lab
The Healthcare Innovation Technology Lab is a pioneering clinical trial sponsor dedicated to advancing medical research through the integration of cutting-edge technology and innovative healthcare solutions. Our mission is to accelerate the development of breakthrough therapies and diagnostics that enhance patient outcomes and improve quality of care. By fostering collaborations between researchers, healthcare providers, and technology developers, we aim to streamline the clinical trial process, ensuring rigorous scientific methodology while prioritizing participant safety and ethical standards. Committed to excellence and transparency, the Healthcare Innovation Technology Lab is at the forefront of transforming healthcare through innovation.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
New York, New York, United States
Patients applied
Trial Officials
Stan Kachnowski, PhD
Principal Investigator
Healthcare Innovation Technology Lab
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported